Population pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients

Are standard dosing regimens of ceftriaxone adapted for critically ill patients with augmented creatinine clearance? A prospective observational study.

(2019) Julien Ollivier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study

(2018) Jeannet C Bos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen

(2018) S. Wilkes et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Allometric size: The scientific theory and extension to normal fat mass

(2017) Nick H.G. Holford et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance

(2017) Nesrine A. Rizk et al.   Expert Review of Anti-Infective Therapy

Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials

(2016) Jason A. Roberts et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Total and unbound ceftriaxone pharmacokinetics in critically ill Australian Indigenous patients with severe sepsis

(2016) Danny Tsai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients

(2015) Michael Schleibinger et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

(2011) Denis Garot et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY